Page 1907 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1334 Index

Cirrhosis, 1026–1031 Colchicine, 338 Conscious sedation
acute on chronic liver failure, 1027 Colistin, 547 in interventional radiology, 209
acute variceal hemorrhage, 1030–1031 Colistin methanesulfonate, 547 in percutaneous abscess drainage, 210
hemodynamic derangements, 1027–1028 Colloids, 571 Consent, request for, 1109–1110
hepatic encephalopathy, 1027, 1027t Colonoscopy, 1018 Constrictive pericarditis, 198, 340–342
liver transplantation, 1031 Coma, 829 cardiac catheterization, 342
pulmonary derangements, 1028 barbiturate, 810 clinical evaluation, 341
hepatic hydrothorax, 1028–1029 differential diagnosis of, 834–835 echocardiography, 341–342, 342f
hepatopulmonary syndrome, 1028 myxedema, 988–990, 989t pathophysiology, 340, 341f
mechanical ventilation, 1028 pentobarbital, 810 treatment of, 342
portopulmonary hypertension, 1028 selected causes of, 835 Content validity, 85
sepsis, 1030 treatment of, 837–838 Continuous positive airway pressure (CPAP), 385
Cisatracurium, 154 Coma cocktail, 1196–1197 Continuous renal replacement techniques
Cisplatin-based chemotherapies, 901–902 Comatose patient (CRRT), 549
Cisplatin infusion, 897 diagnostic procedures in evaluating, Continuous venovenous hemodiafiltration
Clarithromycin, 641 835–837, 836t (CVVHD) drug removal, 549
Clearance, 944–945 examination of, 831–834, 832t, 833f, 834f Contrast-enhanced computed tomography,
Clinical Decision Support System Communication in palliative care, 121–122, in diagnosing right heart
(CDSS), 52, 55 121f, 122t syndromes, 311
Clinical examination, 266, 267t Community-acquired pneumonia Contre-coup brain injury, 1122, 1122f
Clinical informatics, 50 complications, 583–584 Convective clearance, 933
Clinical information system (CIS), 50 criteria for ICU, 582, 582t Convulsions, treatment of, 728
Clinical phenotypes in critical illness, diagnosis of, 581–582, 581t Cooling in treating fever, 561
spectrum of disability and, epidemiology, 580 Coombs test, 861–862
107–108, 108f etiologic spectrum, 580–581, 581t Coronary artery bypass graft (CABG),
Clinical skills, developing and trusting, 2 prevention of, 584 1068–1069
Clopidogrel, 300, 303 treatment of, 583, 583t Coronary sinus perfusion, optimizing, 315–316
Closed intensive-care unit (ICU), 16 Community emergency planning, 61, 61ft Coronary stenting, 300
Closed-loop control, 52 Compartment syndrome, 1174, 1179 Coronavirus, infection control and, 31
Clostridium difficile, 708–711 in burn patients, 1187 Corticosteroids, 499–500, 573
clinical presentation of, 709, 1003 Compassion, combining excellence and, 4–5 adjunctive, 634
colitis, 559 Compensatory anti-inflammatory response indications for, 985
diagnosis of, 709–710, 709f, 1003, 1004f syndrome (CARS), 551, 552 perioperative, in patient on chronic
epidemiology of, 708–709 Complement activation, 565 corticosteroids, 985–986
gastrointestinal infections and, Complement levels, 1249 sepsis and, 573
703–711, 704t Complete heart block, 1071 systemic, 1090
diarrhea, 705–708, 706t Compliance, identifying local barriers to treatment with, 983–985, 984t
esophagitis, 704–705 practice, 33 use of, in critically ill patient, 1250–1251
gastritis, 705 Complications, related to ECMO, 476, 476t, 477t for vasogenic edema, 812–813
host defenses, 704 Comprehensive Unit-Based Safety Program Cortisol physiology, 980–981, 981f
microbiology, 709 (CUSP), 33–34, 34t, 36 Cosmesis, 109, 109f
pathogenesis of, 1003 Compressed gases, diving with, Cost accounting, 39
prevention, 710–711 1319–1321, 1320f Cost-benefit analysis, 38
treatment of, 710, 710t, 1003–1004 Compression fractures, 1147 Cost-effectiveness analysis, 38–39, 40f, 44
Coagulation Computed tomography angiography in intensive-care unit, 37–40, 39f, 40f
acute liver failure and, 1024 (CTA), 219–220 cost accounting, 39
impaired fibrinolysis and, 454 Computed tomography (CT) scan cost-benefit analysis, 38
physiology and mechanism of normal, in diagnosing pulmonary ecbolic cost-effectiveness analysis, 38–39, 40f
846–847 disorders, 324 cost estimates and guesses, 42
Coagulation cascade, soluble clotting factors percutaneous abscess drainage and, 210 cost measurement, 42
and, 846–847, 847t Computer-based patient record, 55 cost-minimization analysis, 38
Coagulation disorders, 332 Computerized physician order entry (CPOE) costs, 40
Coagulation enzymes, antibody inhibitors of, system, 49, 52, 55 cost streams, 42
853–854 Computer use, brief history and current cost-utility analysis, 39
Coagulation factors, disorders of soluble, state of, in intensive-care unit, defining standard care, 42
853–855, 853t 50, 51ft, 52–53 discounting, 42
Coagulation function, laboratory testing of, Confidence intervals, 9, 46–47 economic evaluations in health care, 38
847–849, 848f Confounding, post-randomized, 45–46 methodological considerations in
Coagulation imbalance, 565 Confounding measures, research concepts analysis, 39
Coagulation screening, 511 relevant to quality measurement outcome measures, 39–40
Coagulopathy, 1099 and, 9t, 10 policy implications, 43–44
of trauma and massive transfusion, 856 Confusion Assessment Method ICU, 760 reporting and PCEHM reference case,
Cocaine, 1212–1214, 1213f Conscious, minimal, 830 43, 43f
Coccidioidomycosis, 636 Consciousness, 829 robustness and sensitivity analysis,
Cockroft-Gault equations, 544, 545 impaired, 829, 830–831 42–43, 43f
Cognitive errors, 36 normal and impaired, 829–830, 829t, 830t methodological considerations in, 39

Index.indd 1334 23-01-2015 15:33:51